A detailed history of Ransom Advisory, LTD transactions in Embecta Corp. stock. As of the latest transaction made, Ransom Advisory, LTD holds 48 shares of EMBC stock, worth $589. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48
Holding current value
$589
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 20, 2025

BUY
$12.28 - $20.93 $589 - $1,004
48 New
48 $612,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $711M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Ransom Advisory, LTD Portfolio

Follow Ransom Advisory, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ransom Advisory, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ransom Advisory, LTD with notifications on news.